Stay updated on Intranasal Vasopressin in Autism Children Clinical Trial
Sign up to get notified when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.

Latest updates to the Intranasal Vasopressin in Autism Children Clinical Trial page
- Check4 days agoChange DetectedThe page adds a new metric for the number of participants reporting aggression using the Overt Aggression Scale (OAS) during treatment, including baseline, 4-week, and 8-week time points and the descriptive notes about what the scale captures. It also removes the previous OAS outcome described as 'Change From Baseline in Overt Aggression Scale (OAS) During Treatment' with earlier time points (2-week and 4-week; 6-week and 8-week).SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNew page revision label v3.5.4 added and v3.5.3 removed, updating the page's revision history. This change is an internal metadata update and does not modify study details or user-facing content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a site/software version change rather than a change to the clinical trial record itself.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.0%

- Check82 days agoChange DetectedPage revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Intranasal Vasopressin in Autism Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.